한약을 사용하는 아시아권 국가의 유해사례 보고 양식에 관한 비교 연구
Comparison about adverse drug reaction report forms among Asian’s countries using herbal medicine
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective : The purpose of this study is to find out the possibility of application to herbal medicine’s report form for adverse drug reaction (ADR) by reviewing and analyzing Asian countries’s ADR report forms. Method : We investigated, compared, and analyzed ADR report forms (ADR-RF) of Asian countries’s ADR institutions (ACAI), such as, Korea institute of drug safety & risk management and Dongguk university Ilsan oriental hospital (DUIOH) in Korea, national center for ADR monintoring (NCAM) in China, pharmaceuticals and medical devices agency (PMDA) in Japan, Ministry of Health and Welfare (MOHW) in Taiwan, and drug office, department of health, the government of the Hong Kong special administrative region (GHKSAR) in Hong Kong. Results : ADR-RF for ACAI included common contents, such as, patients information (name(initial), gender, age, weight), adverse event (AE)’s report information (Recognition and report for AE occurrence, first or follow up report, Severe AE), the detailed information of AE (the title of AE, onset & closing date of AE symptoms, the progress & results detailed test of AE), the information of AE’s medicine (the types of medicine, product name, ingredient name, suspected or combination drug, single dose & frequency, dosage form, administration route, dealing for AE-suspected medicine), and AE reporter's information (reporter’s information, institution’s information). Taiwan had ADR-RF and the department exclusively for herbal medicine (HM), but others (except DUIOH) had not only no ADR report form but also contents for HM. Conclusion : ADR-RF for HM have to include the common contents of ACAI at least, as well as HM information related to ADR, such as the title, composition and types of HM, history related to HM’s ADR, and the contents of drug-induced liver injury and so on. In addition, the main department of government for HM’s ADR will be needed.
Abstract
Objective : The purpose of this study is to find out the possibility of application to herbal medicine’s report form for adverse drug reaction (ADR) by reviewing and analyzing Asian countries’s ADR report forms. Method : We investigated, compared, and analyzed ADR report forms (ADR-RF) of Asian countries’s ADR institutions (ACAI), such as, Korea institute of drug safety & risk management and Dongguk university Ilsan oriental hospital (DUIOH) in Korea, national center for ADR monintoring (NCAM) in China, pharmaceuticals and medical devices agency (PMDA) in Japan, Ministry of Health and Welfare (MOHW) in Taiwan, and drug office, department of health, the government of the Hong Kong special administrative region (GHKSAR) in Hong Kong. Results : ADR-RF for ACAI included common contents, such as, patients information (name(initial), gender, age, weight), adverse event (AE)’s report information (Recognition and report for AE occurrence, first or follow up report, Severe AE), the detailed information of AE (the title of AE, onset & closing date of AE symptoms, the progress & results detailed test of AE), the information of AE’s medicine (the types of medicine, product name, ingredient name, suspected or combination drug, single dose & frequency, dosage form, administration route, dealing for AE-suspected medicine), and AE reporter's information (reporter’s information, institution’s information). Taiwan had ADR-RF and the department exclusively for herbal medicine (HM), but others (except DUIOH) had not only no ADR report form but also contents for HM. Conclusion : ADR-RF for HM have to include the common contents of ACAI at least, as well as HM information related to ADR, such as the title, composition and types of HM, history related to HM’s ADR, and the contents of drug-induced liver injury and so on. In addition, the main department of government for HM’s ADR will be needed.
참고문헌 (22)
- 한국인의 한약재 복용실태 조사 연구, "이종태", 한양대학교, 식품의약품안전처, ~, pp.1470001444 (2006)
- Heinrich M, "Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources", Journal of ethnopharmacology, 125(1), pp.108~144 (2009)
- Suk KT, "A prospective nationwide study of drug-induced liver injury in Korea", The American journal of gastroenterology, 107(9), pp.1380~1387 (2012)
- 김미경, "인터넷 신문기사에 보도된 한약 유해사례 분석", 대한한의학회지, 36(1), pp.33~44 (2015), 대한한의학회
- 배수현, "한방병원 입원환자의 한⋅양방 약물 병용에 따른 간 기능 안전성 평가 : 전향적 관찰연구", 대한한방내과학회지, 34(2), pp.192~203 (2013), 대한한방내과학회
- Zhou L, "Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout", PLoS One, 9(1), pp.e85008~ (2014)
- Calitz C, "Herbal hepatotoxicity : current status, examples, and challenges", Expert opinion on drug metabolism & toxicology, 11(10), pp.1551~1565 (2015)
- Teschke R, "Traditional Chinese Medicine Induced Liver Injury", Journal of clinical and translational hepatology, 2(2), pp.80~94 (2014)
- 식품의약품안전처, "식품의약품안전처 고시 제2014-97호 의약품등 안전성 정보관리 규정 제2조", ~ (2014)
- 한국의약품안전관리원, "약물역학연구 수행사례 나눔터(약수터) 제1호", ~ (2012)
- 권영주, "1개 대학 한방병원에서 EMR을 통해 보고된 한약에 의한 약물유해반응의 현황", 대한한방내과학회지, 33(4), pp.485~497 (2012), 대한한방내과학회
- 김미경, "EMR의 자발적 약물부작용보고 시스템을 이용한 한약약물유해반응 분석", 대한한의학회지, 36(1), pp.45~60 (2015), 대한한의학회
- "한국 의약품 안전관리원"[URL]
- "醫藥品醫療機器統合機構 (Pharmaceuticals and medical devices agency)"[URL]
- "國家藥品不良反應監測中心"[URL]
- "衛生福利部中醫藥司"[URL]
- "香港特別行政區政府 衛生署 藥物辦公室 (Drug Office, Department of Health, The Government of the Hong Kong Speicial Administrative Region (GHKSAR))"[URL]
- 국내 유해사례 보고자료 관리 및 활용방안연구, "정면우", 식품의약품안전처, ~ (2010)
- 법제처, "법률 제13320호. 약사법 제2조", ~ (2015)
- 한의약제제표준화연구, "김윤경", 원광대학교, 식품의약품안전처, ~, pp.1475006662 (2011)
- Itoh T, "Clinical characteristics of side effects induced by administration of Glycyrrhize radix and Scutellaria radix under the therapy based on Kampo diagnosis in out hospital", Kamp Med, 61(3), pp.299~307 (2010)
- 윤영주, "간손상 관련 한약 안전성 연구의 개선을 위한 한약인성 간손상 조사표 제안", 대한한방내과학회지, 30(1), pp.181~190 (2009), 대한한방내과학회